Owlet, Inc. Class A Common Stock OWLT 深 滬
已收盤 07-18 16:00:00 美东时间
8.02
-0.010
-0.12%
華盛通- 最 高8.21
- 今 開8.02
- 成交量 1.57万股
- 最 低 7.8625
- 昨 收 8.03
- 總市值 1.33亿
- 52周最高 9.7425
- 市盈率 靜 --
- 換手率 0.09%
- 52周最低 2.75
- 委 比 0.00%
- 總股本 1652.47万
- 歷史最高 161.84
- 量 比 0.19
- 振 幅 4.33%
- 歷史最低 2.5214
- 每 手 1
- 風險率 1.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) stock rose 35.9% to $0.73 during Friday's regular...
06-14 01:06
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Theriva Biologics (AMEX:TOVX) stock moved upwards by 47.4% to $0.72 du...
06-03 05:05
Owlet shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.
Owlet shares are trading higher after the company reported better-than-expected...
05-10 03:08
Owlet Raises FY2025 Sales Guidance from $88.00M-$92.00M to $91.00M-$95.00M vs $109.97M Est
Owlet (NYSE:OWLT) raises FY2025 sales outlook from $88.00 million-$92.00 million to $91.00 million-$95.00 million vs $109.97 million estimate.
05-09 04:13
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
Owlet, Inc. Reports Record Growth and Expansion
Owlet Inc (($OWLT)) has held its Q4 earnings call. Read on for the main highlig...
03-06 08:25
Owlet (OWLT) Receives a Buy from Lake Street
In a report released today, Ben Haynor from Lake Street maintained a Buy rating...
03-05 21:57
Owlet Sees FY2025 Sales $88.000M-$92.000M vs $88.92M Est
Owlet (NYSE:OWLT) sees FY2025 sales of $88.000 million-$92.000 million vs $88.92 million analyst estimate.
03-05 05:23
Earnings Scheduled For March 4, 2025
Companies Reporting Before The Bell • 908 Devices (NASDAQ:MASS) is likely to re...
03-04 16:32
美股大行评级 | 潜在涨幅75%！Solar Edge获高盛升目标价至31美元，维持买入评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1099980218194210816.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：维持Chemomab Therapeutics(CMMB)"买入"评级，目标价从4美元升至7美元</p> <p>• Citizens Capital Markets：维持德纳维制药(DVAX)"跑赢
02-24 11:50
